Stockscreener 앱 받기
0.01%
시장 영업 전:
전일 마감가:
$366.21
열려 있는:
$369.38
하루 거래량:
2.09M
Relative Volume:
0.76
시가총액:
$197.43B
수익:
$36.74B
순이익/손실:
$7.71B
주가수익비율:
25.73
EPS:
14.2333
순현금흐름:
$8.10B
1주 성능:
-2.84%
1개월 성능:
-0.80%
6개월 성능:
+34.12%
1년 성능:
+16.75%
1일 변동 폭
$364.72
$370.89
1주일 범위
$364.72
$380.14
52주 변동 폭
$261.43
$391.29
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
366.25 | 197.43B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
989.12 | 883.28B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.19 | 586.06B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
221.45 | 391.56B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
192.01 | 297.77B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.87 | 295.52B | 54.72B | 14.02B | 15.32B | 7.1855 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 개시 | Jefferies | Hold |
| 2026-02-20 | 개시 | Barclays | Equal Weight |
| 2026-01-20 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-12-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2025-11-24 | 재개 | Truist | Hold |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-09-03 | 재개 | Raymond James | Mkt Perform |
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
National Bank of Canada FI Purchases 863,216 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Shs Thailand Depositary Receipts Repr 1 Sh Trade Ideas — SET:AMGN06 - TradingView
Focus Partners Wealth Acquires 8,839 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Trimmed by CSM Advisors LLC - MarketBeat
Alliancebernstein L.P. Sells 444,604 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen And Sanofi End Repatha IP Fight Heard By Justices - Law360
Here’s Why Amgen’s Free Cash Flow Could Nearly Double in 2026 - TIKR.com
Is Amgen Inc. (AMGN) a Good Buy at the Moment? - Bitget
Is Trending Stock Amgen Inc. (AMGN) a Buy Now? - Yahoo Finance Singapore
Biotechnology Market Is Booming So Rapidly | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report - Benzinga
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report - Benzinga
Hilltop Holdings Inc. Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat
Elevation Point Wealth Partners LLC Buys 5,370 Shares of Amgen Inc. $AMGN - MarketBeat
Bank of Nova Scotia Purchases 60,794 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Decreased by Ameriprise Financial Inc. - MarketBeat
Amgen Inc. Stock Holds Defensive Ground Near 366 USD as Biotech Giant Targets 12% Annual Gain - AD HOC NEWS
Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus - simplywall.st
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies - Insider Monkey
Amgen’s TrumpRx Discounts and Dividend Hike Might Change The Case For Investing In Amgen (AMGN) - Yahoo Finance
Chevy Chase Trust Holdings LLC Sells 9,383 Shares of Amgen Inc. $AMGN - MarketBeat
California Public Employees Retirement System Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock (ISIN: US0311621009) Demonstrates Defensive Strength Amid Market Volatility - AD HOC NEWS
Aristotle Capital Management LLC Sells 153,136 Shares of Amgen Inc. $AMGN - MarketBeat
How Investors May Respond To Amgen (AMGN) Dividend, Obesity Drug Focus, And Cardiovascular Trial Updates - simplywall.st
Amgen (AMGN) and GSK (GSK) Expand Reach with TrumpRx Partnership - GuruFocus
Amgen and GSK said to be adding products on TrumpRx - Seeking Alpha
Amgen Inc. Stock (ISIN: US0311621009) Gains Defensive Appeal Amid Leadership Shift and Biotech Resil - AD HOC NEWS
M&T Bank Corp Trims Position in Amgen Inc. $AMGN - MarketBeat
Capital Wealth Planning Reduces Amgen Stake - National Today
Harvest Fund Management Co. Ltd Sells 4,234 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock Dips Amid TrumpRx Partnership News as Valuation Stands Firm - AD HOC NEWS
Comerica Bank Has $46.70 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Capital Wealth Planning LLC Sells 472,530 Shares of Amgen Inc. $AMGN - MarketBeat
GSK and Amgen to add medicines to TrumpRx, Fox Business reports - Reuters
Two major drug companies are the latest to join TrumpRx - Fox Business
Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar - Law360
Amgen obtains EPA ENERGY STAR 2025 certification - WJournalpr
Amgen Inc. Stock (ISIN: US0311621009) Hits Defensive Strength Amid Biotech Shifts - AD HOC NEWS
Starbucks, Amgen, CVS and Other Stocks Help This Income Fund Shine - Barron's
Amgen vs Sanofi – A chronology of the patent battle over Repatha and Praluent - JUVE Patent
Amgen Inc. $AMGN Shares Sold by Martingale Asset Management L P - MarketBeat
Invesco Ltd. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Mackenzie Financial Corp - MarketBeat
Amgen Inc. $AMGN Shares Bought by American Investment Services Inc. - MarketBeat
Advisory Research Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen and Sanofi end epic battle over Praluent and Repatha - JUVE Patent
Is It Time To Reassess Amgen (AMGN) After Its Strong 1 Year Share Price Run? - simplywall.st
Amgen: MariTide And Osteoporosis Sales Fuel The Rally (NASDAQ:AMGN) - Seeking Alpha
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
암젠 주식 (AMGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
0.15%
0.16%
자본화:
|
볼륨(24시간):